Cancer deaths are higher among organ transplant recipients

the ONA take:

Transplant patients receive drugs to prevent rejection of the new organ; however, because those drugs suppress the patient’s immune system, they are more susceptible to cancers many years later.

In particular, transplant recipients in Australia have a high risk of skin cancer because of its high UV levels. Researchers at the University of Adelaide are working on understanding this risk and how cancers can be prevented in this population.

This research has uncovered a number of biomarkers that indicate if a transplant patient may be more likely to develop cancer.

The researchers note, however, that they as of yet have no real way of preventing those cancers from occurring. But in an effort to find a balance between ensuring transplanted organs are not rejected and reducing the risk of cancers in these patients, the research team is conducting further studies to determine what the impact reducing immunosuppressants will have on patients.

Psychological problems in men experiencing cancer
This research has uncovered a number of biomarkers that indicate if a transplant patient may be more likely to develop cancer
Researchers at the University of Adelaide are working to better understand how patients who receive life-saving organ transplants can be spared from dying of cancer many years later. Transplant patients are 3-5 times more likely to develop cancer than the general population.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs